drugset / Trial / NCT07494175

Study on the Mass Balance of [14C]HRS-9190 for Injection in Healthy Participants

NCT07494175

Phase 1 Active not recruiting 6 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the absorption, metabolism and excretion after a single intravenous bolus of \[14C\]HRS-9190 in healthy Participants

Timeline

Start
2026-04-11
Primary completion
2026-05
Completion
2026-05

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-9190 Unknown Intravenous

Indications

No indication recorded.